Published online January 3, 2005
PEDIATRICS Vol. 115 No. 1 January 2005, pp. 83-88 (doi:10.1542/peds.2004-0865)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marlier, L.
Right arrow Articles by Messer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marlier, L.
Right arrow Articles by Messer, J.
Related Collections
Right arrow Premature & Newborn

Olfactory Stimulation Prevents Apnea in Premature Newborns

Luc Marlier, PhD*, Christophe Gaugler, MD{ddagger} and Jean Messer, MD{ddagger}

* Centre National de la Recherche Scientifique, UMR 5170, site of Strasbourg, France
{ddagger} Centre Hospitalier Régional Universitaire de Hautepierre, Pédiatrie 2, Strasbourg, France

Objective. Methylxanthines and doxapram are currently used to treat apnea of prematurity but are not fully effective and often present undesirable side effects. The present study examines whether exposure to an odor known to modulate the infant's respiratory rate could reduce the frequency of apneic spells.

Method. Fourteen preterm newborns born at 24 to 28 gestational weeks presenting recurrent apnea despite caffeine and doxapram therapy were exposed to a pleasant odor diffused during 24 hours in the incubator. Efficiency of the olfactory treatment was judged by comparing frequency and severity of apneas occurring during the day of odorization with that observed the day before (baseline) and the day after (posttreatment control). Apnea was defined as any complete cessation of breathing movements for >20 seconds, or less if associated with hypoxia or bradycardia.

Results. Concerning all types of apneas, a diminution of 36% was observed and seen in 12 of 14 infants. Apneas without bradycardia were reduced (44%) during the day with odorization, and this diminution affected all the infants. The frequency of apnea with moderate bradycardia (heart rate between 70 and 90 beats per minute) was maintained while the frequency of apnea associated with severe bradycardia (heart rate <70 beats per minute) decreased strongly (45%) and affected all the infants. No side effects were observed.

Conclusion. The introduction of a pleasant odor in the incubator is of therapeutic value in the treatment of apneas unresponsive to caffeine and doxapram.

Key Words: premature newborn • apnea • olfaction • incubator • health • neonatal adaptation

Abbreviations: RR, respiratory rate • HR, heart rate • SpO2, oxygen saturation • bpm, beats per minute

Accepted Jun 21, 2004.




This article has been cited by other articles:


Home page
 PediatricsHome page
D. K. Ng, L. C. Leung, T.-f. Tong, C.-h. Chan, and S.-f. Wong
Airway Obstruction in Premature Newborns: A Missing Link
Pediatrics, June 1, 2005; 115(6): 1789 - 1789.
[Full Text] [PDF]

Home page
 PediatricsHome page
L. Marlier, C. Gaugler, and J. Messer
Airway Obstruction in Premature Newborns: A Missing Link: In Reply
Pediatrics, June 1, 2005; 115(6): 1789 - 1790.
[Full Text] [PDF]